IRadimed Corporation achieves record Q4 2024 revenue, driven by IV pump demand and monitor sales focus. Learn about their growth strategy & 2025 outlook.

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Reports Q4 revenue $19.4M vs $17.5M last year. “We are proud to close out 2024 with another record-breaking quarter, marking our fourteenth ...

A full-time nurse, Ashley Emerson, first learned about infusion therapy on a trip to Arizona a few years back. The vitamin ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

On January 22, 2025, the Lions Club of Penetanguishene presented a cheque for $5,200 to Victoria Evans, community Giving ...

ARTE Partlyist, Rotary Club Foundation, and former beauty queen Shamcey Supsup Lee offer their combined support to the cancer patients at Jose Reyes Memorial Medical Center in Manila. The Rotary Club ...

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...